مرکزی مواد پر جائیں

فوری جراحی مسائل کے لیے قریبی ہسپتال کے ایمرجنسی شعبے سے رابطہ کریں۔

Empyema & VATS Surgery

عام طور پر صحت یابی: Recovery depends on the severity and stage of pleural infection and the treatment required. Patients treated successfully with antibiotics and chest-tube drainage may improve over several days but often remain in hospital until infection, drainage and breathing are clearly improving. After uncomplicated VATS debridement, chest drains usually remain until the pleural space is adequately drained and the lung is expanded; hospital recovery commonly takes several days, followed by progressive recovery at home over the next few weeks. Recovery after extensive decortication or open thoracotomy is usually longer. Persistent infection, air leak, underlying lung disease or poor nutrition can prolong recovery.

اہم نکات

  • Pleural infection is a spectrum that includes complicated parapneumonic effusion and empyema.
  • Empyema means frank pus in the pleural space, but pleural infection can require drainage even when the sampled fluid is not visibly purulent.
  • Pleural fluid pH, glucose, LDH, Gram stain/culture, imaging and the overall clinical picture help determine whether an infected pleural effusion requires drainage.
  • Thoracic ultrasound is useful for confirming pleural fluid, identifying septations and guiding safe drainage.
  • CT can define loculation, pleural thickening, lung entrapment and alternative intrathoracic pathology when needed.
  • Current BTS guidance recommends initial drainage of established pleural infection with a small-bore chest tube of 14 F or smaller.
  • Chest-tube diameter alone does not determine success; correct positioning, patency and access to the relevant locule are more important.
  • Antibiotics are required, but antibiotics alone are usually insufficient once an infected pleural collection requires drainage.
  • Pleural-fluid culture is often negative, particularly after antibiotics; microbiology should be interpreted alongside the clinical and imaging findings.
  • When chest-tube drainage stops but a substantial residual infected collection remains, combined intrapleural tPA and DNase can be considered in suitable patients.
  • Single-agent tPA or DNase should not be assumed to have the same evidence as the combined regimen.
  • Intrapleural fibrinolytic/enzyme treatment carries bleeding risk and must be individualised, especially in patients receiving anticoagulation or with other bleeding risks.
  • Persistent fever, sepsis, inadequate drainage, enlarging loculations or failure of lung re-expansion should prompt early reassessment rather than prolonged ineffective drainage.
  • VATS means video-assisted thoracoscopic surgery; it describes the minimally invasive access route rather than one specific operation.
  • For empyema, VATS may involve drainage, adhesiolysis, breakdown of loculations, pleural washout and debridement.
  • Decortication is different from simple drainage or debridement: it removes a fibrous visceral pleural peel when that peel prevents the lung from expanding.
  • Current BTS guidance recommends considering VATS access over thoracotomy when surgical treatment of adult pleural infection is required.
  • VATS should not be chosen merely for smaller incisions if it cannot achieve adequate clearance and lung re-expansion.
  • Conversion from VATS to thoracotomy is not a failure; it is sometimes the safest way to complete adequate surgery in dense chronic disease.
  • Not every patient with empyema needs decortication. The extent of surgery should reflect empyema stage, degree of lung entrapment and patient fitness.
  • A chronically trapped lung with a mature pleural peel is more likely to require decortication than an early fibrinopurulent empyema.
  • Bronchopleural fistula, postoperative empyema, oesophageal perforation, tuberculosis, fungal disease or malignancy-associated pleural infection require cause-specific planning beyond routine parapneumonic empyema treatment.
  • Nutrition, mobilisation, respiratory physiotherapy, venous-thromboembolism prevention and treatment of the underlying pneumonia are important parts of recovery.
  • Earlier recognition of failed drainage generally gives a better opportunity for less invasive definitive treatment than waiting until dense chronic organisation develops.

جائزہ

Empyema is infection within the pleural space, the thin space between the lung and chest wall. It usually develops as a complication of pneumonia but can also follow thoracic surgery, trauma, oesophageal perforation or other infections. The term pleural infection includes complicated parapneumonic effusion and empyema; empyema specifically refers to frank pus within the pleural cavity. Treatment has three goals: control infection with appropriate antibiotics, drain the infected pleural collection effectively and allow the lung to re-expand. Not every empyema requires surgery as the first step. Current British Thoracic Society guidance recommends initial drainage of established pleural infection with a small-bore chest tube, alongside antibiotics and supportive care. When drainage becomes inadequate because the infected fluid is loculated by fibrinous septations, combined intrapleural tissue plasminogen activator (tPA) and DNase can be considered in suitable patients. Surgery is considered when pleural sepsis persists, drainage is inadequate, the collection remains organised or loculated, there is a trapped lung, or the clinical course indicates that non-operative treatment is unlikely to achieve adequate source control. Video-assisted thoracoscopic surgery (VATS) is a minimally invasive surgical access technique performed through small chest incisions using a camera; it is not one single operation. In empyema, VATS can be used to break loculations, drain pus, remove fibrin and infected debris, wash the pleural space and assess whether the lung can expand. Decortication is a more extensive procedure in which a fibrous peel restricting the lung is removed to allow re-expansion. Current BTS guidance favours VATS access over thoracotomy when surgery is required in suitable adults, but the operation must still achieve effective clearance and lung expansion. Some advanced, chronic or technically difficult empyemas require conversion to open thoracotomy or planned open surgery. The extent of surgery should therefore be tailored to empyema stage, lung entrapment, anatomy and patient fitness rather than applying the same operation to every patient.

علامات

  • Fever or recurrent fever during or after treatment for pneumonia.
  • Pleuritic chest pain that worsens with deep breathing or coughing.
  • Shortness of breath.
  • Persistent cough.
  • Fatigue, weakness and reduced appetite.
  • Failure to improve as expected despite appropriate treatment for pneumonia.
  • Persistent or recurrent inflammatory markers and systemic illness.
  • A pleural effusion or loculated pleural collection seen on chest imaging.
  • Reduced breath sounds over the affected side.
  • Sepsis or respiratory deterioration in severe pleural infection.

معائنہ اور علاج کی منصوبہ بندی کیسے ہوتی ہے

  1. 1

    Assess airway, breathing, circulation, oxygenation and the severity of sepsis or respiratory compromise.

  2. 2

    Review the history for pneumonia, recent thoracic surgery, trauma, aspiration, oesophageal disease, tuberculosis risk and immune suppression.

  3. 3

    Perform chest imaging, usually chest radiography followed by thoracic ultrasound and/or CT according to the clinical situation.

  4. 4

    Sample pleural fluid when appropriate for pH, glucose, LDH, cell count, Gram stain, culture and other tests guided by the differential diagnosis.

  5. 5

    Start antibiotics appropriate to whether the infection is community-acquired, healthcare-associated or postoperative, then refine therapy using microbiology and clinical response.

  6. 6

    Drain established pleural infection using image-guided chest-tube placement, usually with a small-bore tube as recommended by current BTS guidance.

  7. 7

    Confirm drain position and function when the patient fails to improve or residual loculated collections remain.

  8. 8

    Consider combined intrapleural tPA and DNase when initial chest-tube drainage has ceased or remains inadequate with a residual pleural collection and the patient is an appropriate candidate.

  9. 9

    Reassess clinical status, inflammatory markers and imaging rather than continuing ineffective tube drainage indefinitely.

  10. 10

    Obtain thoracic surgical input when source control remains inadequate, there is persistent pleural sepsis, significant organised loculation, trapped lung, fistula or another surgical indication.

  11. 11

    When surgery is required and feasible, use VATS access to inspect the pleural cavity and perform drainage, adhesiolysis, washout and debridement as needed.

  12. 12

    Assess whether the lung re-expands after infected material and fibrin are cleared.

  13. 13

    Perform visceral pleural decortication when a restrictive fibrous peel is preventing adequate lung expansion and the patient's condition and empyema stage justify the additional procedure.

  14. 14

    Convert to thoracotomy or use an open approach when adequate clearance or safe decortication cannot be achieved thoracoscopically.

  15. 15

    Leave appropriately positioned chest drains after surgery and monitor air leak, drainage, lung expansion and infection control.

  16. 16

    Continue antibiotics for a duration guided by source control, organism, clinical response and specialist judgement rather than using one fixed duration for every patient.

  17. 17

    Begin mobilisation, chest physiotherapy, nutrition optimisation and pulmonary rehabilitation as clinical stability allows.

تیاری

  • Bring previous chest X-rays, CT scans and pleural ultrasound reports and images when available.
  • Bring pleural-fluid reports including pH, Gram stain, culture and tuberculosis or cytology results if already performed.
  • Provide details of antibiotics already taken and the dates they were started.
  • Tell the surgical team about previous chest surgery, trauma, tuberculosis, pneumonia or recurrent pleural infection.
  • Bring a complete medication list, especially anticoagulants and antiplatelet drugs.
  • Do not stop anticoagulation without a specific plan; this is particularly important if intrapleural tPA-DNase or surgery is being considered.
  • Tell the team about chronic lung disease, heart disease, kidney disease, diabetes, malnutrition or immune suppression.
  • If surgery is likely, follow fasting and anaesthetic instructions provided by the treating team.
  • Ask whether the planned operation is VATS drainage/debridement, possible decortication, or whether conversion to thoracotomy may be necessary.

صحت یابی اور بعد کی دیکھ بھال

  • Perform breathing exercises, incentive spirometry and chest physiotherapy as advised to promote lung expansion.
  • Mobilise early when medically safe because prolonged immobility increases pulmonary and thrombotic complications.
  • Keep chest drains and dressings protected and report sudden increased drainage, bleeding or air leak to the clinical team.
  • Complete the prescribed antibiotic plan unless it is deliberately modified by the treating team.
  • Attend follow-up imaging to confirm lung re-expansion and resolution of the pleural collection when advised.
  • Seek reassessment for recurrent fever, increasing breathlessness, worsening chest pain or deterioration after discharge.
  • Maintain adequate calorie and protein intake because prolonged pleural infection commonly causes nutritional depletion.
  • After VATS, temporary discomfort at port sites and around the chest drain is common; persistent severe neuropathic or worsening pain should be reviewed.
  • After decortication or thoracotomy, gradually increase activity according to respiratory recovery and wound healing.
  • Continue treatment and follow-up for the underlying cause, such as pneumonia, tuberculosis, postoperative fistula or another disease process.

خطرات اور ممکنہ پیچیدگیاں

  • Persistent or recurrent pleural infection.
  • Failure of chest-tube drainage.
  • Bleeding associated with intrapleural fibrinolytic/enzyme therapy.
  • Sepsis and organ dysfunction.
  • Trapped lung from organised pleural fibrosis.
  • Respiratory failure.
  • Need for VATS or open thoracic surgery.
  • Conversion from VATS to thoracotomy.
  • Bleeding during or after surgery.
  • Prolonged postoperative air leak.
  • Bronchopleural fistula.
  • Persistent pleural space or recurrent empyema.
  • Pneumonia or atelectasis after surgery.
  • Wound or port-site infection.
  • Postoperative pain or intercostal neuralgia.
  • Venous thromboembolism.
  • Need for prolonged drainage, reoperation or open-window procedures in complex refractory cases.
  • Reduced pulmonary function when chronic pleural restriction or underlying lung disease persists.

طبی مدد کب لیں

  • URGENT: Increasing breathlessness or low oxygen levels during treatment for pneumonia.
  • URGENT: Persistent high fever or sepsis despite appropriate pneumonia treatment.
  • URGENT: A known pleural effusion associated with systemic illness, chest pain or respiratory deterioration.
  • URGENT: Rapid worsening after chest-tube drainage or sudden respiratory distress.
  • URGENT: Significant bleeding through a chest drain or after intrapleural fibrinolytic treatment.
  • SOON: Failure to improve after chest-tube drainage of pleural infection.
  • SOON: Persistent loculated pleural collection on imaging despite apparently functioning drainage.
  • SOON: Continued fever, inflammatory markers or pleural sepsis after several days of treatment.
  • SOON: Failure of the lung to re-expand after adequate drainage.
  • SOON: Persistent air leak suggesting a bronchopleural fistula.
  • SOON: Recurrent empyema after previous drainage or surgery.
  • SOON: Empyema associated with tuberculosis, malignancy, recent thoracic surgery or oesophageal disease because treatment may require a different pathway.

غلط فہمی اور حقیقت

اکثر پوچھے جانے والے سوالات

حوالہ جات

Medically reviewed by Dr. Shams Alam Mohammed Tahir, MBBS, MS (General Surgery). Last reviewed 2026-09-20.

WhatsApp